Treating HCV infection in children
Christine K. Lee, Maureen M. Jonas – 4 March 2015 – Watch a video presentation of this article
Laparoscopic liver resection
David A. Geller, Mohammad Khreiss – 4 March 2015 – Watch a video presentation of this article
Los nuevos tratamiento de hepatitis C: Perspectivas latinoamericanas
Rafael Claudino Botero, Martín Tagle A – 4 March 2015 – Watch a video presentation of this article
Accesibilidad a los nuevos agentes antivirales directos contra la infeccion por VHC. Un punto de vista desde España
Santiago Tome, Esteban Otero – 4 March 2015 – Watch a video presentation of this article
Laparoscopic liver resection
David A. Geller, Mohammad Khreiss – 4 March 2015 – Watch a video presentation of this article
Treating HCV infection in children
Christine K. Lee, Maureen M. Jonas – 4 March 2015 – Watch a video presentation of this article
Access to new direct‐acting antiviral agents against HCV infection: A view from Spain
Santiago Tomé, Esteban Otero – 4 March 2015 – Watch a video presentation of this article
New therapies for hepatitis C: Latin American perspectives
Rafael Claudino Botero, Martin Tagle – 4 March 2015 – Watch a video presentation of this article
Successful liver transplantation in a child with acute‐on‐chronic liver failure and acquired thrombotic thrombocytopenic purpura
Delphine Arni, Fabienne Gumy‐Pause, Marc Ansari, Johanna A. Kremer Hovinga, Valérie A. McLin – 27 February 2015
Multicenter experience using simeprevir and sofosbuvir with or without ribavirin to treat hepatitis C genotype 1 after liver transplant
Surakit Pungpapong, Bashar Aqel, Michael Leise, K. Tuesday Werner, Jennifer L. Murphy, Tanisha M. Henry, Kristen Ryland, Amy E. Chervenak, Kymberly D. Watt, Hugo E. Vargas, Andrew P. Keaveny – 26 February 2015 – Treatment with an all‐oral interferon‐free antiviral regimen using simeprevir and sofosbuvir with or without ribavirin (RBV) for 12 weeks resulted in high sustained virologic response (SVR) rates along with minimal adverse events in non–liver transplant (LT) patients with hepatitis C virus (HCV) genotype 1 infection.